Showing results (11-20 of 58) with videos related to
Sort By:
Pageof 6
Upsala Journal of Medical Sciences|December 4, 2025
Enhancing Recruitment Using Teleconference and Commitment Contract (ERUTECC): a stepped wedge cluster randomised trial within the EFFECTS trialEva Isaksson, Per Näsman, Per Wester, et al.Risk Analysis : an Official Publication of the Society for Risk Analysis|January 10, 2018
A Systems-Based Risk Assessment Framework for Intentional Electromagnetic Interference (IEMI) on Critical InfrastructuresBenjamin Donald Oakes, Lars-Göran Mattsson, Per Näsman, et al.Trials|November 1, 2019
Identifying important barriers to recruitment of patients in randomised clinical studies using a questionnaire for study personnelEva Isaksson, Per Wester, Ann Charlotte Laska, et al.European Neurology|October 7, 2020
Validation of the Simplified Modified Rankin Scale QuestionnaireEva Isaksson, Per Wester, Ann Charlotte Laska, et al.European Journal of Clinical Investigation|April 12, 2014
Lipid-lowering treatment and inflammatory mediators in diabetes and chronic kidney diseaseTora Almquist, Stefan H Jacobson, Fariborz Mobarrez, et al.European Journal of Heart Failure|January 28, 2014
Is the prognosis in patients with diabetes and heart failure a matter of unsatisfactory management? An observational study from the Swedish Heart Failure RegistryIsabelle Johansson, Magnus Edner, Ulf Dahlström, et al.Heart (British Cardiac Society)|June 3, 2015
Risk factors, treatment and prognosis in men and women with heart failure with and without diabetesIsabelle Johansson, Ulf Dahlström, Magnus Edner, et al.Diabetes & Vascular Disease Research|September 5, 2018
Type 2 diabetes and heart failure: Characteristics and prognosis in preserved, mid-range and reduced ventricular functionIsabelle Johansson, Ulf Dahlström, Magnus Edner, et al.Journal of the American College of Cardiology|September 24, 2016
Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart FailureIsabelle Johansson, Ulf Dahlström, Magnus Edner, et al.ERJ Open Research|December 14, 2020
Adherence to disease-specific drug treatment among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertensionBarbro Kjellström, Anna Sandqvist, Clara Hjalmarsson, et al.Pageof 6